The vision of the UroPrint consortium is to laser print fully functional immunocompatible urothelial tissue ex vivo and in vivo for bladder augmentation and replacement.

read more

  • OVERVIEW

    A number of conditions, including trauma, inflammation, incontinence, overactive bladder, renal impairments, neurological disorders (like spinal cord injury or spina bifida) and cancer, require bladder augmentation. For almost a century now, the majority of cystoplasties utilize bowel segments (enterocystoplasty).

    read more

  • OBJECTIVES

    UroPrint's overall objective will be achieved through the parallel pursuing of the individual but interconnected objectives outlined here

    read more

  • IMPACT

    UroPrint envisions to provide a viable solution to an existing medical problem while substantially advancing technologies and concepts that could impact other fields in regenerative medicine.

    read more